vs

Side-by-side financial comparison of OMNICELL, INC. (OMCL) and Waystar Holding Corp. (WAY). Click either name above to swap in a different company.

Waystar Holding Corp. is the larger business by last-quarter revenue ($313.9M vs $309.9M, roughly 1.0× OMNICELL, INC.). Waystar Holding Corp. runs the higher net margin — 13.8% vs 3.7%, a 10.1% gap on every dollar of revenue. On growth, Waystar Holding Corp. posted the faster year-over-year revenue change (22.4% vs 14.9%). Waystar Holding Corp. produced more free cash flow last quarter ($90.3M vs $38.6M). Over the past eight quarters, Waystar Holding Corp.'s revenue compounded faster (15.7% CAGR vs 5.8%).

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

Waystar Holding Corp is a leading provider of integrated healthcare payment and revenue cycle management solutions. It serves healthcare providers, health systems, and payers across the United States, offering tools that streamline billing, claims processing, patient payment collection, and revenue optimization to reduce administrative burdens and improve financial performance for healthcare organizations.

OMCL vs WAY — Head-to-Head

Bigger by revenue
WAY
WAY
1.0× larger
WAY
$313.9M
$309.9M
OMCL
Growing faster (revenue YoY)
WAY
WAY
+7.5% gap
WAY
22.4%
14.9%
OMCL
Higher net margin
WAY
WAY
10.1% more per $
WAY
13.8%
3.7%
OMCL
More free cash flow
WAY
WAY
$51.6M more FCF
WAY
$90.3M
$38.6M
OMCL
Faster 2-yr revenue CAGR
WAY
WAY
Annualised
WAY
15.7%
5.8%
OMCL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
OMCL
OMCL
WAY
WAY
Revenue
$309.9M
$313.9M
Net Profit
$11.4M
$43.3M
Gross Margin
45.3%
Operating Margin
25.6%
Net Margin
3.7%
13.8%
Revenue YoY
14.9%
22.4%
Net Profit YoY
261.7%
47.9%
EPS (diluted)
$0.25
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OMCL
OMCL
WAY
WAY
Q1 26
$309.9M
$313.9M
Q4 25
$314.0M
$303.5M
Q3 25
$310.6M
$268.7M
Q2 25
$290.6M
$270.7M
Q1 25
$269.7M
$256.4M
Q4 24
$306.9M
$244.1M
Q3 24
$282.4M
$240.1M
Q2 24
$276.8M
$234.5M
Net Profit
OMCL
OMCL
WAY
WAY
Q1 26
$11.4M
$43.3M
Q4 25
$20.0M
Q3 25
$5.5M
$30.6M
Q2 25
$5.6M
$32.2M
Q1 25
$-7.0M
$29.3M
Q4 24
$19.1M
Q3 24
$8.6M
$5.4M
Q2 24
$3.7M
$-27.7M
Gross Margin
OMCL
OMCL
WAY
WAY
Q1 26
45.3%
Q4 25
41.5%
Q3 25
43.3%
Q2 25
43.9%
Q1 25
41.1%
Q4 24
46.2%
Q3 24
43.3%
Q2 24
41.3%
Operating Margin
OMCL
OMCL
WAY
WAY
Q1 26
25.6%
Q4 25
0.1%
19.4%
Q3 25
2.7%
22.4%
Q2 25
2.8%
24.0%
Q1 25
-4.3%
25.4%
Q4 24
4.0%
21.8%
Q3 24
2.3%
11.3%
Q2 24
1.2%
3.5%
Net Margin
OMCL
OMCL
WAY
WAY
Q1 26
3.7%
13.8%
Q4 25
6.6%
Q3 25
1.8%
11.4%
Q2 25
1.9%
11.9%
Q1 25
-2.6%
11.4%
Q4 24
7.8%
Q3 24
3.1%
2.3%
Q2 24
1.3%
-11.8%
EPS (diluted)
OMCL
OMCL
WAY
WAY
Q1 26
$0.25
$0.42
Q4 25
$-0.05
$0.10
Q3 25
$0.12
$0.17
Q2 25
$0.12
$0.18
Q1 25
$-0.15
$0.16
Q4 24
$0.34
$0.18
Q3 24
$0.19
$0.03
Q2 24
$0.08
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OMCL
OMCL
WAY
WAY
Cash + ST InvestmentsLiquidity on hand
$239.2M
$34.3M
Total DebtLower is stronger
$13.5M
Stockholders' EquityBook value
$1.3B
$3.9B
Total Assets
$2.0B
$5.8B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OMCL
OMCL
WAY
WAY
Q1 26
$239.2M
$34.3M
Q4 25
$196.5M
$61.4M
Q3 25
$180.1M
$421.1M
Q2 25
$399.0M
$290.3M
Q1 25
$386.8M
$224.0M
Q4 24
$369.2M
$182.1M
Q3 24
$570.6M
$127.1M
Q2 24
$556.8M
$68.4M
Total Debt
OMCL
OMCL
WAY
WAY
Q1 26
$13.5M
Q4 25
$1.5B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
OMCL
OMCL
WAY
WAY
Q1 26
$1.3B
$3.9B
Q4 25
$1.2B
$3.9B
Q3 25
$1.2B
$3.2B
Q2 25
$1.3B
$3.2B
Q1 25
$1.3B
$3.1B
Q4 24
$1.2B
$3.1B
Q3 24
$1.2B
$3.1B
Q2 24
$1.2B
$2.9B
Total Assets
OMCL
OMCL
WAY
WAY
Q1 26
$2.0B
$5.8B
Q4 25
$2.0B
$5.8B
Q3 25
$1.9B
$4.7B
Q2 25
$2.1B
$4.7B
Q1 25
$2.2B
$4.6B
Q4 24
$2.1B
$4.6B
Q3 24
$2.3B
$4.5B
Q2 24
$2.3B
$4.6B
Debt / Equity
OMCL
OMCL
WAY
WAY
Q1 26
0.00×
Q4 25
0.38×
Q3 25
Q2 25
Q1 25
Q4 24
0.40×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OMCL
OMCL
WAY
WAY
Operating Cash FlowLast quarter
$54.5M
$84.9M
Free Cash FlowOCF − Capex
$38.6M
$90.3M
FCF MarginFCF / Revenue
12.5%
28.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.80×
1.96×
TTM Free Cash FlowTrailing 4 quarters
$110.8M
$314.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OMCL
OMCL
WAY
WAY
Q1 26
$54.5M
$84.9M
Q4 25
$30.4M
$66.6M
Q3 25
$28.3M
$82.0M
Q2 25
$42.8M
$96.8M
Q1 25
$25.9M
$64.2M
Q4 24
$56.3M
Q3 24
$22.8M
$78.8M
Q2 24
$58.7M
$15.4M
Free Cash Flow
OMCL
OMCL
WAY
WAY
Q1 26
$38.6M
$90.3M
Q4 25
$22.6M
$57.2M
Q3 25
$18.5M
$76.2M
Q2 25
$31.0M
$91.0M
Q1 25
$14.8M
$58.8M
Q4 24
$47.2M
Q3 24
$13.9M
$70.2M
Q2 24
$49.1M
$8.6M
FCF Margin
OMCL
OMCL
WAY
WAY
Q1 26
12.5%
28.8%
Q4 25
7.2%
18.9%
Q3 25
6.0%
28.3%
Q2 25
10.7%
33.6%
Q1 25
5.5%
22.9%
Q4 24
15.4%
Q3 24
4.9%
29.2%
Q2 24
17.8%
3.7%
Capex Intensity
OMCL
OMCL
WAY
WAY
Q1 26
Q4 25
2.5%
3.1%
Q3 25
3.1%
2.2%
Q2 25
4.1%
2.1%
Q1 25
4.1%
2.1%
Q4 24
3.0%
Q3 24
3.1%
3.6%
Q2 24
3.5%
2.9%
Cash Conversion
OMCL
OMCL
WAY
WAY
Q1 26
4.80×
1.96×
Q4 25
3.33×
Q3 25
5.18×
2.68×
Q2 25
7.58×
3.01×
Q1 25
2.20×
Q4 24
Q3 24
2.64×
14.56×
Q2 24
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

WAY
WAY

Subscription$172.2M55%
Volume-based$139.5M44%

Related Comparisons